BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 281 filers reported holding BLUEBIRD BIO INC in Q2 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,676 | -8.1% | 98,578 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $326,228 | +3.8% | 99,158 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $314,384 | -29.6% | 98,863 | +53.2% | 0.00% | 0.0% |
| Q4 2022 | $446,622 | +263.1% | 64,541 | +225.5% | 0.00% | – |
| Q3 2022 | $123,000 | +28.1% | 19,826 | -15.4% | 0.00% | – |
| Q2 2022 | $96,000 | -71.9% | 23,444 | -67.0% | 0.00% | -100.0% |
| Q1 2022 | $342,000 | -62.5% | 70,959 | -22.3% | 0.00% | 0.0% |
| Q4 2021 | $912,000 | -61.3% | 91,374 | -26.0% | 0.00% | -75.0% |
| Q3 2021 | $2,356,000 | -44.5% | 123,412 | -7.0% | 0.00% | -42.9% |
| Q2 2021 | $4,243,000 | -41.4% | 132,717 | -44.8% | 0.01% | -46.2% |
| Q1 2021 | $7,240,000 | -24.1% | 240,243 | +9.1% | 0.01% | -31.6% |
| Q4 2020 | $9,536,000 | -7.8% | 220,217 | +15.0% | 0.02% | -13.6% |
| Q3 2020 | $10,338,000 | +15.2% | 191,442 | +30.0% | 0.02% | +10.0% |
| Q2 2020 | $8,976,000 | +203.7% | 147,262 | +128.7% | 0.02% | +150.0% |
| Q1 2020 | $2,956,000 | +154.0% | 64,385 | +384.9% | 0.01% | +300.0% |
| Q4 2019 | $1,164,000 | -44.9% | 13,278 | -42.3% | 0.00% | -50.0% |
| Q3 2019 | $2,114,000 | -4.1% | 23,020 | +32.8% | 0.00% | 0.0% |
| Q2 2019 | $2,205,000 | -36.4% | 17,334 | -21.4% | 0.00% | -33.3% |
| Q1 2019 | $3,469,000 | +77.6% | 22,043 | +11.9% | 0.01% | +50.0% |
| Q4 2018 | $1,953,000 | +357.4% | 19,691 | +573.0% | 0.00% | +300.0% |
| Q3 2018 | $427,000 | -85.4% | 2,926 | -84.2% | 0.00% | -83.3% |
| Q2 2018 | $2,915,000 | -25.8% | 18,576 | -19.3% | 0.01% | -14.3% |
| Q1 2018 | $3,931,000 | -12.6% | 23,026 | -8.0% | 0.01% | -12.5% |
| Q4 2017 | $4,498,000 | -13.0% | 25,032 | -33.5% | 0.01% | -11.1% |
| Q3 2017 | $5,171,000 | +26.6% | 37,657 | -3.2% | 0.01% | +28.6% |
| Q2 2017 | $4,084,000 | +32.9% | 38,882 | +15.0% | 0.01% | +16.7% |
| Q1 2017 | $3,074,000 | +108.1% | 33,823 | +42.1% | 0.01% | +100.0% |
| Q4 2016 | $1,477,000 | – | 23,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |